Company Genomictree Inc.

Equities

A228760

KR7228760005

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
20,150 ^KRW	-1.71%		-3.36%	-2.18%

2023	Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.	CI

Genomictree Inc. is a Korea-based company mainly engaged in the genomic analysis. The Company is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials for molecular diagnostic products. Molecular diagnostic products include cancer molecular diagnostic products and molecular genetic diagnostic products. Cancer molecular diagnostic products include molecular diagnostic products for colorectal cancer, bladder cancer, lung cancer, stomach cancer, cervical cancer. Molecular genetic diagnostic products include epidermal growth factor receptor (EGFR) mutation diagnosis, as well as human papilloma virus (HPV) diagnostic products.

KRW in Million	2022	Weight	2023	Weight	Delta
Cancer Molecular Diagnosis 53.3 %	1,778	6.0 %	1,822	53.3 %	+2.45%
Genome Analysis and Others 46.7 %	28,088	94.0 %	1,596	46.7 %	-94.32%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 54.8 %	1,820	6.1 %	1,873	54.8 %	+2.90%
United States 44.8 %	28,034	93.9 %	1,530	44.8 %	-94.54%
Others 0.4 %	11	0.0 %	15	0.4 %	+33.10%

Managers	Title	Age	Since
Chi-Wang Yoon FOU	Founder	62	05/10/00
Sung-Whan An FOU	Founder	63	05/10/00
Hong Sun Lee DFI	Director of Finance/CFO	-	-
Tae-Jeong Oh CTO	Chief Tech/Sci/R&D Officer	58	-
Jik-Yeol Yoo AUD	Comptroller/Controller/Auditor	57	-

Members of the board	Title	Age	Since
Sung-Whan An FOU	Founder	63	05/10/00
Chi-Wang Yoon FOU	Founder	62	05/10/00
Tae-Jeong Oh CTO	Chief Tech/Sci/R&D Officer	58	-
Dong-Jun Jeong BRD	Director/Board Member	52	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,362,333	19,176,645 ( 78.71 %)	380,360 ( 1.561 %)	78.71 %

Name	Equities	%	Valuation
Sung-Whan An 13.53 %	3,249,103	13.53 %	52 M ₩
KB Investment Co., Ltd. 4.200 %	1,008,533	4.200 %	16 M ₩
Chi-Wang Yoon 3.457 %	830,071	3.457 %	13 M ₩
GENOMICTREE INC. 1.584 %	380,360	1.584 %	6 M ₩
ORION HOLDINGS CORP. 1.421 %	341,297	1.421 %	5 M ₩
Se-hwan Ahn 1.063 %	255,178	1.063 %	4 M ₩
Dayli Partners Co. Ltd. 0.9868 %	236,960	0.9868 %	4 M ₩
Tae-Jeong Oh 0.5649 %	135,647	0.5649 %	2 M ₩
Young-sup Lee 0.4289 %	102,992	0.4289 %	2 M ₩
Jung-wook Sung 0.4190 %	100,600	0.4190 %	2 M ₩

Name	Equities	%	Valuation
GENOMICTREE INC. 1.58%	380,360	1.58%	6,082,017 $

Genomictree, Inc.

44-6 Techno 10-ro Yuseong-gu

34027, Daejeon

http://www.genomictree.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENOMICTREE INC.	-2.18%	357M
MODERNA, INC.	+33.63%	50.93B
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B

Other Biotechnology & Medical Research